Plasma Extracellular Vesicles Identify Patients With Prodromal‐ and Alzheimer's Disease Through Their Proteomic Content
Preliminary results suggest that the biomarkers signature of pEVs could inform about the AD pathology in the prodromal stages of AD continuum. However, further experiments are still needed for a better understanding of the EVs' role in the AD development and pathology dissemination.
Authors
- Laura Montrreal (ORCID: https://orcid.org/0000-0002-0010-645X)
- M. Carrasco
- Montserrat Alegret (ORCID: https://orcid.org/0000-0002-8164-9500)
- C. Olive (ORCID: https://orcid.org/0000-0001-6682-4502)
- Miren Ettcheto (ORCID: https://orcid.org/0000-0002-4301-7297)
- Rosanna Rossi (ORCID: https://orcid.org/0000-0002-3656-2908)
- Pablo García‐González (ORCID: https://orcid.org/0000-0003-0125-5403)
- Laura María Díaz Guzmán
- Marta Marquié
- María Luisa Sarrate Capdevila
- Raquel Puerta
- Pamela Martino‐Adami
- Antonio Camins
- Mercè Boada
- Amanda Cano
- Alfredo Ramirez
- Maria Isabel Pividori
- Mercè Martí
- Agustin Ruiz
- Álvaro Muñoz‐Morales
Institutions
- Universitat Autònoma de Barcelona (ES)
- The University of Texas at San Antonio Health Science Center (US)
- University of Cologne (DE)
- Universitat Internacional de Catalunya (ES)
- Fundació ACE (ES)
- University Hospital Cologne (DE)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_100924
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00